Skip to main content

Table 2 Preoperative and POD1 global QoR-40 Score

From: Comparison of the effects of remimazolam and dexmedetomidine on the quality of recovery in functional endoscopic sinus surgery: a randomized clinical trial

 

Group R (n = 40)

Group D (n = 40)

Group C (n = 40)

P-value

Preoperative

 Total QoR-40 Score

161.0 (158.0 -164.0)

162.0 (159.0 -163.0)

162.0 (158.3 -163.8)

0.928

POD1

 Emotional state

35.0 (33.8 -36.3)*

34.5 (33.8—36.0)*

29.5 (28.8—31.0)

 < 0.001

 Physical comfort

42.5 (42.0—44.3)*

42.0 (40.0—43.3)*

40.0 (38.0—41.3)

0.004

 Physical independence

22.0 (21.0—22.0)

22.0 (20.8—22.0)

20.5 (20.0—22.0)

0.219

 Psychological support

28.0 (26.8—29.0)

28.0 (26.0—29.0)

27.0 (26.0—28.0)

0.475

 Pain

29.0 (28.0—30.3)*

30.0 (28.0—30.3)*

25.5 (24.8—27.0)

 < 0.001

 Total QoR-40 Score

154.5 (152.0 -159.0)*

155.0 (154.8 -159.3)*

139.0 (136.8 -142.0)

 < 0.001

  1. Variables are presented as the median and interquartile range
  2. Group R iv. remimazolam, Group D iv. dexmedetomidine, Group C iv. placebo, POD1 postoperative day 1, QoR-40 quality of recovery 40
  3. *p < 0.05 vs. group C